The condition is often linked to a structural brain abnormality called Chiari-like malformation (CM), where the back of the skull is too small to properly accommodate the brain. This crowding can obstruct normal CSF flow between the brain and spinal cord. When cerebrospinal fluid becomes disrupted or forced into the spinal cord tissue, it can gradually form syrinxes. Over time, these fluid pockets enlarge and cause progressive spinal cord damage.
Clinical signs of Syringomyelia can vary widely depending on severity. Some dogs may show mild symptoms, while others experience significant neurological pain and disability. Common early signs include sensitivity around the neck, scratching at the shoulder or ear area (often without actually touching the skin), and discomfort when wearing a collar. Dogs may also exhibit intermittent pain, vocalization, or reluctance to be touched.
As the condition progresses, symptoms may become more severe and include weakness, difficulty walking, incoordination (ataxia), muscle atrophy, and episodes of intense pain, especially in the neck or head region. Some dogs may develop scoliosis (curvature of the spine) or show signs of neuropathic pain such as air scratching or phantom scratching movements. In advanced cases, neurological deficits may significantly affect quality of life.
The Syringomyelia (SM) Health Test typically involves imaging-based evaluation, most commonly MRI scanning, as well as genetic risk assessment in predisposed breeds. While a single definitive genetic mutation has not been identified for all cases, certain breeds show a strong inherited predisposition, making screening and selective breeding important tools for disease reduction. MRI allows veterinarians to visualize the brain and spinal cord directly, confirming the presence and severity of syrinx formation and associated structural abnormalities.
Results are generally interpreted based on clinical and imaging findings:
- Clear / No Evidence of SM: No syrinx formation or related spinal cord abnormalities detected.
- Mild / At Risk: Small syrinxes or early structural changes present; may or may not cause clinical signs.
- Affected: Significant syrinx formation and spinal cord damage consistent with symptomatic Syringomyelia.
Because Syringomyelia is a progressive condition, severity can change over time. Regular monitoring may be recommended for dogs diagnosed at an early stage or those showing mild abnormalities.
Genetic and clinical screening for SM is especially important in breeds such as Cavalier King Charles Spaniels and related brachycephalic breeds, where Chiari-like malformation is common. Breeders can use test results to reduce the prevalence of structural skull abnormalities and lower the risk of producing affected offspring. Selecting breeding dogs with healthier cranial and neurological structures helps improve long-term breed health.
For dog owners, understanding SM status allows for better management of pain and neurological symptoms. Treatment may include pain relief medications, anti-inflammatory drugs, and in some cases, surgical decompression to improve CSF flow. Early diagnosis can significantly improve comfort and slow progression.
The Syringomyelia (SM) Health Test is an important diagnostic and screening tool that supports early detection, informed breeding decisions, and improved neurological health outcomes in predisposed dog breeds.
